Tissue Plasminogen Activator

The tissue plasminogen activator test measures the amount of tPA protein in your blood plasma. tPA is made by the cells that line your blood vessels and helps your body break down clots by converting plasminogen into plasmin, an enzyme that dissolves fibrin. Most laboratories report tPA antigen, which reflects the total circulating protein rather than how active it is.

This test may be ordered alone or alongside other markers that show clot formation and breakdown, such as plasminogen, PAI one, fibrinogen, or D dimer. Your blood is usually collected into a citrate tube to prevent clotting and processed promptly to keep proteins stable.

Clinicians use tPA levels to evaluate the balance between making clots and clearing them, especially when there are symptoms of unusual clotting or bleeding, or conditions that stress the lining of blood vessels. Levels can change during acute illness, infection, liver disease, or treatment with clot busting medicines. Lower values may suggest reduced fibrinolytic capacity, while higher values can reflect increased release or reduced clearance, often considered together with its inhibitor PAI one.

The result is most informative when interpreted with your history, examination, and other laboratory tests that assess coagulation and fibrinolysis. It may be used in the evaluation of suspected thrombotic risk, disorders of excessive fibrinolysis, or complex conditions such as disseminated intravascular coagulation.

Your result is interpreted in the context of why you were tested, your symptoms, and related laboratory findings. A single value rarely provides a complete picture. Your clinician may compare it with tests that show clot formation and breakdown, or repeat testing when you are well, since tPA can shift with stress, exercise, or acute illness.

If your level falls outside the expected range, your care team may review medications, timing of the draw, and recent procedures. Recent use of a thrombolytic drug such as alteplase can influence the measurement. You might be asked to return for a fasting morning sample, or to have additional tests that look at inhibitors, clotting factors, or markers of inflammation. Discuss any new swelling, chest discomfort, shortness of breath, or unusual bleeding with your clinician promptly.